Reduced Daylight Linked to Seasonal Affective Disorder, Researchers Find

As winter approaches and daylight diminishes, many people experience seasonal affective disorder (SAD), with symptoms like low mood and poor concentration. Research suggests that individuals with SAD have reduced sensitivity to blue light, which normally helps regulate alertness and mood. Light therapy using bright artificial light has proven effective in alleviating symptoms for many patients.

On November 4, 2026, the Associated Press reported on new findings linking reduced daylight exposure to seasonal affective disorder (SAD), particularly during winter months when shorter days and darker afternoons coincide with symptom onset. The article highlights research from the University of Pittsburgh led by Kathryn Roecklein, PhD, which found that individuals with SAD exhibit diminished sensitivity to blue light—especially in winter—compromising their brain’s ability to regulate alertness and mood through natural light cues. This physiological insight builds on earlier work by Norman Rosenthal, MD, who first described SAD in 1984 at the NIH, establishing it as a recognized condition with seasonal patterns. The article notes that while SAD affects more women than men and is often mistaken for general depression, its distinct seasonal onset—fall to spring—distinguishes it clinically. Light therapy, recommended by experts like Paul Desan, MD, PhD, at Yale’s Winter Depression Research Clinic, has been shown effective when administered using devices emitting 10,000 lux of bright light for 30 minutes daily in the morning. However, not all commercially available lights meet this standard, and some may be ineffective due to insufficient brightness. Insurance coverage for such devices varies, prompting institutions like Yale and the nonprofit Center for Environmental Therapeutics to offer consumer guidance. While antidepressants and cognitive behavioral therapy (CBT) are also re